Celine Perier
Saumya (Sam) Krishnan
Saumya (Sam) Krishnan
Celine trained as a Neuroscientist and obtained her PhD in the laboratory of Pr. Etienne Hirsch at the University of Paris VI (Paris, France). She joined the group of Pr. Serge Przedborski at Columbia University (New York, USA) as a post-doctoral researcher and then joined the group of Dr. Miquel Vila in Barcelona (Spain). During this tim
Celine trained as a Neuroscientist and obtained her PhD in the laboratory of Pr. Etienne Hirsch at the University of Paris VI (Paris, France). She joined the group of Pr. Serge Przedborski at Columbia University (New York, USA) as a post-doctoral researcher and then joined the group of Dr. Miquel Vila in Barcelona (Spain). During this time, she studied the role of mitochondria in Parkinson’s disease pathogenesis. Before joining the QBI at UCSF, she was a Project Manager/Grant Writer at the Center for Emerging and Neglected Diseases at the University of California Berkeley. She is passionate about science communication and believes that scientific storytelling and building collaborations are crucial elements for the advancement of science.
Saumya (Sam) Krishnan
Saumya (Sam) Krishnan
Saumya (Sam) Krishnan
Sam received her PhD in Microbiology from the Pennsylvania State University studying regulation of gene expression by signaling molecules released during antibiotic-mediated stress. She received her postdoctoral training at the University of Wisconsin-Madison with Dr. Richard Gourse, where she discovered and elucidated a fine-tuning role
Sam received her PhD in Microbiology from the Pennsylvania State University studying regulation of gene expression by signaling molecules released during antibiotic-mediated stress. She received her postdoctoral training at the University of Wisconsin-Madison with Dr. Richard Gourse, where she discovered and elucidated a fine-tuning role for viral proteins in modulating host RNA polymerase structure and function. She now manages the multidisciplinary Antiviral Drug Discovery research group at UCSF which focuses on finding novel solutions for COVID-19 and other viruses of pandemic potential. Sam is passionate about science advocacy and building a strong scientific community based on evidence-based research and inclusive collaboration.